63
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers

, , , , , , , , & show all
Pages 357-370 | Published online: 20 Jan 2016

References

  • AdamHJLaingNMKingCRLulashnykBHobanDJZhanelGGIn vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolatesAntimicrob Agents Chemother2009534915492019738018
  • ChenYHLiuCYLuJJKingCHHsuehPRIn vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in TaiwanJ Antimicrob Chemother2009641226122919833635
  • LauderdaleTLShiauYRLaiJFChenHCKingCHComparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolatesAntimicrob Agents Chemother2010541338134220065058
  • van RensburgDJPerngRPMithaIHEfficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaAntimicrob Agents Chemother2010544098410620660689
  • QinXHuangHReview of nemonoxacin with special focus on clinical developmentDrug Des Devel Ther20148765774
  • GuoBWuXZhangYSafety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral dosesClin Drug Investig201232475486
  • LinLChangLWTsaiCYDose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteersAntimicrob Agents Chemother20095440541019884368
  • ChungDTTsaiCYChenSJMultiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteersAntimicrob Agents Chemother20105441141719884374
  • ZhangYFDaiXJWangTEffects of an Al3+− and Mg2+− containing antacid, ferrous sulfate, and calcium carbonate on the absorption of nemonoxacin (TG-873870) in healthy Chinese volunteersActa Pharmacol Sin2014351586159225327812
  • LandersdorferCBKirkpatrickCMKinzigMCompetitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecidBr J Clin Pharmacol20106916717820233180
  • LandersdorferCBKirkpatrickCMKinzigMCompetitive inhibition of renal tubular secretion of gemifloxacin by probenecidAntimicrob Agents Chemother2009533902390719564368
  • NakashimaMUematsuTKosugeKSingle- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansAntimicrob Agents Chemother199539263526408592993
  • FishDNChowATThe clinical pharmacokinetics of levofloxacinClin Pharmacokinet1997321011199068926
  • MulgaonkarAVenitzJGründemannDSweetDHHuman organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobialsAntimicrob Agents Chemother2013572705271123545524
  • AllenABirdNDixonREffect of cimetidine on the pharmacokinetics of oral gemifloxacin in healthy volunteersClin Drug Invest200121519526
  • MulgaonkarA1VenitzJSweetDHFluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transportersExpert Opin Drug Metab Toxicol2012855356922435536
  • StassHSachseREffect of probenecid on the kinetics of a single oral 400 mg dose of moxifloxacin in healthy male volunteersClin Pharmacokinet200140Suppl 1717611352445
  • SörgelFGrannemanGRStephanULockeCEffect of cimetidine on the pharmacokinetics of temafloxacinClin Pharmacokinet199222Suppl 175821319874
  • MisiakPM1EldonMAToothakerRDSedmanAJEffects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacinJ Clin Pharmacol199313353568429114